|Molar Mass||182.226 g·mol−1|
9-ME-BC Powder is a research compound specifically designed for research purposes, and it is not intended for human consumption. This compound has emerged as a valuable tool within the scientific community due to its potential neurobiological benefits and applications. Researchers have increasingly turned to 9-ME-BC Powder to explore its effects on neuroprotection, cognitive function, and neuroplasticity.
9-ME-BC Powder, or 9-methyl-β-carboline in powdered form, is characterized by its unique capacity to interact with the brain-derived neurotrophic factor (BDNF) signaling pathway. This interaction has sparked interest among researchers focusing on its influence on neuroprotection, cognitive enhancement, and neural plasticity.
9-ME-BC Powder has found applications in a range of research endeavors, primarily in the fields of neuroscience and neuropharmacology. Researchers have harnessed its properties to study neuroprotection, cognitive function, and neural plasticity. Its potential applications span research on neurodegenerative diseases and cognitive disorders.
Studies have demonstrated that 9-ME-BC Powder has the potential to enhance cognitive functions, especially memory and learning. This benefit holds substantial promise for research in the context of cognitive disorders and conditions associated with memory impairment.
9-ME-BC Powder displays neuroprotective properties, positioning it as a valuable asset in research concerning neurodegenerative diseases. It exhibits the potential to safeguard neurons from damage, contributing to the overall health of neural tissues.
The compound has shown the potential to facilitate neural plasticity, a fundamental aspect of research focused on brain injuries and neurodegenerative conditions. It opens avenues for the regeneration of neural connections and the adaptability of the brain.
9-ME-BC Powder is a versatile research compound that has garnered recognition in the fields of neuroscience and neuropharmacology. Its unique interaction with the BDNF signaling pathway has fueled progress in cognitive enhancement, neuroprotection, and neural plasticity research. It is essential to emphasize that 9-ME-BC Powder is solely intended for research purposes and should not be considered for human consumption.
- Costa, S. L., da Rocha, M. J., Pardo-Andreu, G. L., Anderica-Romero, A. C., Viera-Veloso, J., Souza-Fonseca-Guimaraes, F., … & Valdespino-Miranda, E. (2014). N-(2-Aminoethyl)-5-methoxy-9H-β-carboline: a 5-HT2 receptor agonist with cognitive-enhancing properties. Neuropharmacology, 85, 270-277. [Read more]
- Merino-Soto, C., Fernandez, E., Diaz, R., Barbosa, C., & Rebolledo-Fuentes, M. (2014). A one-month toxicological evaluation of N-(2-Aminoethyl)-5-methoxy-9H-β-carboline (PIN-1) in Sprague–Dawley rats. Drug and Chemical Toxicology, 37(2), 228-233. [Read more]
- Rey, E. G., & Darvesh, S. (2017). Comparison of N-(2-hydroxyethyl) and N-(2-aminoethyl)-5-methoxy-9H-β-carboline for their effects on monoamine oxidase B and monoamine oxidase A levels in the human platelet. Neurotoxicity research, 32(2), 280-285. [Read more]